J&J targets $100B revenue, Replimune rebuffed again and a “Revolution” in pancreatic cancer
BioSpace · BioSpace
April 15, 202617m 53s
Audio is streamed directly from the publisher (api.riverside.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.